Interventional management of atrial fibrillation

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 7, 2010, Pages 949-958

  Arora, Sandeep ^a   Mookadam, Farouk ^a   Srivathsan, Komandoor ^a  

^a MAYO CLINIC   (United States)

Author keywords

ablation; atrial fibrillation; interventional

Indexed keywords

ANTIARRHYTHMIC AGENT; WARFARIN;

ARTIFICIAL HEART PACEMAKER; BLEEDING; CATHETER ABLATION; DEEP VEIN THROMBOSIS; DEFIBRILLATOR; DISEASE MANAGEMENT; DRUG EFFICACY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART PACING; HEART TAMPONADE; HEMATOMA; HUMAN; INFECTION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; PATHOPHYSIOLOGY; PATIENT MONITORING; PATIENT SELECTION; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; STROKE; SURGICAL APPROACH; TREATMENT INDICATION; ATRIAL FIBRILLATION; CARDIOVERSION; COMPARATIVE STUDY; DRUG ADMINISTRATION; ELECTROCARDIOGRAPHY; HEALTH SURVEY; HEART ATRIOVENTRICULAR NODE; HEART SURGERY; SURGERY; TACHYCARDIA;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC PACING, ARTIFICIAL; CARDIAC SURGICAL PROCEDURES; CATHETER ABLATION; DRUG ADMINISTRATION SCHEDULE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY, AMBULATORY; FOLLOW-UP STUDIES; HUMANS; PATIENT SELECTION; POPULATION SURVEILLANCE; RISK ASSESSMENT; TACHYCARDIA;

EID: 77954461057     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.53     Document Type: Review

References (43)

1. Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119(3), 480-486 (2009).
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98(10), 946-952 (1998).
3. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med. 347(23), 1825-1833 (2002).
4. Carlsson J, Miketic S, Windeler J et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J. Am. Coll. Cardiol. 41(10), 1690-1696 (2003).
5. Roy D, Talajic M, Nattel S et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N. Engl. J. Med. 358(25), 2667-2677 (2008).
6. Corley SD, Epstein AE, DiMarco JP et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109(12), 1509-1513 (2004).
7. Haïssaguerre M, Jaïs P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339(10), 659-666 (1998).
8. Ho SY, Cabrera JA, Tran VH, Farre J, Anderson RH, Sanchez-Quintana D. Architecture of the pulmonary veins: relevance to radiofrequency ablation. Heart 86(3), 265-275 (2001).
9. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92(7), 1954-1968 (1995).
10. Polyakova V, Miyagawa S, Szalay Z, Risteli J, Kostin S. Atrial extracellular matrix remodelling in patients with atrial fibrillation. J. Cell Mol. Med. 12(1), 189-208 (2008).
11. Schauerte P, Scherlag BJ, Pitha J et al. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation 102(22), 2774-2780 (2000).
12. Steven D, Reddy VY, Inada K et al. Loss of pace capture on the ablation line: a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation. Heart Rhythm 7(3), 323-330 (2010).
13. Oral H, Scharf C, Chugh A et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 108(19), 2355-2360 (2003). (Pubitemid 37413542)
14. Karch MR, Zrenner B, Deisenhofer I et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 111(22), 2875-2880 (2005).
15. Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293(21), 2634-2640 (2005).
16. Pappone C, Augello G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J. Am. Coll. Cardiol. 48(11), 2340-2347 (2006).
17. Jaïs P, Cauchemez B, Macle L et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 118(24), 2498-2505 (2008).
18. Oral H, Pappone C, Chugh A et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N. Engl. J. Med. 354(9), 934-941 (2006).
19. Elayi CS, Verma A, Di Biase L et al. Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. Heart Rhythm 5(12), 1658-1664 (2008).
20. Tzou WS, Marchlinski FE, Zado ES et al. Long term outcome after successful catheter ablation of atrial fibrillation. Circ. Arrhythm. Electrophysiol. DOI: 10.1161/ CIRCEP.109.923771 (2010) (Epub ahead of print).
21. Bertaglia E, Tondo C, De Simone A et al. Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience. Europace 12(2), 181-187 (2010).
22. Shinagawa K, Derakhchan K, Nattel S. Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy. Pacing Clin. Electrophysiol. 26(3), 752-764 (2003).
23. Piccini JP, Lopes RD, Kong MH et al. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ. Arrhythm. Electrophysiol. 2(6), 636-1633 (2009).
24. Wilber DJ, Pappone C, Neuzil P et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 303(4), 333-340 (2010).
25. Stabile G, Bertaglia E, Senatore G et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study). Eur. Heart J. 27(2), 216-221 (2006).
26. Cappato R, Calkins H, Chen SA et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ. Arrhythm. Electrophysiol 3(1), 32-38 (2010).
27. Van Belle Y, Janse P, Rivero-Ayerza MJ et al. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur. Heart J. 28(18), 2231-2237 (2007).
28. Nademanee K, McKenzie J, Kosar E et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J. Am. Coll. Cardiol. 43(11), 2044-2053 (2004).
29. Oral H, Chugh A, Yoshida K et al. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J. Am. Coll. Cardiol. 53(9), 782-789 (2009).
30. Verma A, Mantovan R, Macle L et al. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial. Eur. Heart J. DOI: 10.1093/eurheartj/ehq041 (2010) (Epub ahead of print).
31. Calkins H, Brugada J, Packer DL et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Heart Rhythm 4(6), 816-861 (2007).
32. Piorkowski C, Kottkamp H, Tanner H et al. Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J. Cardiovasc. Electrophysiol. 16(12), 1286-1292 (2005).
33. Bertaglia E, Zoppo F, Tondo C et al. Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety. Heart Rhythm 4(10), 1265-1271 (2007).
34. Themistoclakis S, Corrado A, Marchlinski FE et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J. Am. Coll. Cardiol. 55(8), 735-743 (2010).
35. Ballaux PK, Geuzebroek GS, van Hemel NM et al. Freedom from atrial arrhythmias after classic maze III surgery: a 10-year experience. J. Thorac. Cardiovasc. Surg. 132(6), 1433-1440 (2006).
36. Prasad SM, Maniar HS, Camillo CJ et al. The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J. Thorac. Cardiovasc. Surg. 126(6), 1822-1828 (2003).
37. Sie HT, Beukema WP, Misier AR et al. Radiofrequency modified maze in patients with atrial fibrillation undergoing concomitant cardiac surgery. J. Thorac. Cardiovasc. Surg. 122(2), 249-256 (2001).
38. Williams MR, Garrido M, Oz MC, Argenziano M. Alternative energy sources for surgical atrial ablation. J. Card. Surg. 19(3), 201-206 (2004).
39. Shen J, Bailey MS, Damiano RJ Jr. The surgical treatment of atrial fibrillation. Heart Rhythm 6, S45-S50 (2009).
40. Wolf RK, Schneeberger EW, Osterday R et al. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J. Thorac. Cardiovasc. Surg. 130(3), 797-802 (2005).
41. Edgerton JR, McClelland JH, Duke D et al. Minimally invasive surgical ablation of atrial fibrillation: six-month results. J. Thorac. Cardiovasc. Surg. 138(1), 109-113 (2009).
42. Khan MN, Jaïs P, Cummings J et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N. Engl. J. Med. 359(17), 1778-1785 (2008).
43. Ogawa H, Ishikawa T, Matsushita K et al. Effects of right atrial pacing preference in prevention of paroxysmal atrial fibrillation: Atrial Pacing Preference study (APP study). Circ. J. 72(5), 700-704 (2008).